| Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120) |
|---|
| 04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 04/29/2004 | WO2003060078A8 Heterocyclic modulators of nuclear receptors |
| 04/29/2004 | WO2002085909A8 9-deazaguanine derivatives as inhibitors of gsk-3 |
| 04/29/2004 | US20040082787 Chemical compounds |
| 04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/29/2004 | US20040082564 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors |
| 04/29/2004 | US20040082555 Use of gaba, inverse agonists in combination with nicotine receptor partial agonist, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders |
| 04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 04/28/2004 | EP1412363A1 Gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
| 04/28/2004 | CN1492762A Azoles as malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 04/28/2004 | CN1147494C Novel benzodiazine compound, its preparation method and medicine composition containing them |
| 04/28/2004 | CN1147493C Oxazolo, thiazole and selenazolo [4,5-C]-quinolin-4-amines and analoges thereof and pharmaceutical composition containing them |
| 04/28/2004 | CN1147489C New bicyclo aminopyrazineone compound, its production process and medical composition containing them |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727246 Enhancement of cognition and memory in human diseases such as alzheimer's |
| 04/27/2004 | US6727053 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent |
| 04/22/2004 | WO2004033465A1 2' oxo-voruscharin and derivatives thereof |
| 04/22/2004 | WO2004033427A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/22/2004 | WO2004014852A3 Iminothiazolidinones as inhibitors of hcv replication |
| 04/22/2004 | WO2003051300A8 Metal complexes and formulations of rifamycin analogues and uses therof |
| 04/22/2004 | WO2003051299A8 Sulfhydryl rifamycins and uses thereof |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077646 Indole nitriles |
| 04/22/2004 | US20040077533 Methods and compositions for treating bacterial infections and diseases associated therewith |
| 04/22/2004 | CA2501611A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/21/2004 | CN1146568C Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 04/15/2004 | US20040072836 Substituted aza-oxindole derivatives |
| 04/14/2004 | EP1408043A1 2''oxo-voruscharin and analogues thereof |
| 04/14/2004 | EP1406906A1 Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
| 04/14/2004 | EP1406889A2 Interaction inhibitors of tcf-4 with beta-catenin |
| 04/13/2004 | US6720316 Therapeutic 5-HT ligand compounds |
| 04/08/2004 | WO2004014893A3 Antimicrobial aza-bicyclic derivates, their compositions and uses |
| 04/08/2004 | WO2004014361A9 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 04/08/2004 | US20040067991 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 04/08/2004 | US20040067944 Antiarrhythmia agents |
| 04/07/2004 | EP1405852A1 Diamine derivatives |
| 04/07/2004 | CN1487940A Lactam compounds and medicinal use thereof |
| 04/07/2004 | CN1487933A Pyrazole compounds useful as protein kinase inhibitors |
| 04/07/2004 | CN1144797C Polycyclic thiazolidin-2-ylidene amines, producing process thereof and use as medicine |
| 04/01/2004 | WO2004027046A2 Methods of producing 4-amino-3-mercapto-triazoles |
| 04/01/2004 | WO2004026881A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
| 04/01/2004 | WO2004026880A1 Novel compound |
| 04/01/2004 | WO2004026835A1 Novel compound |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063753 N-acetoamino-4-one-Pyridine derivatives are used as Lp-PLA2 (lipoprotein Associated Phospholipase A2) enzyme inhibitor |
| 04/01/2004 | US20040063713 Such as 2-((4-(2-fluorophenyl)-1-piperazinyl)methyl)-1H-thieno(3,4-d)imidazole |
| 04/01/2004 | US20040063580 For killing weeds in paddy fields or farmlands, and are not harmful to a rice plant, wheat, barley, maize, cotton, soybeans |
| 04/01/2004 | CA2498762A1 Monosodium salt of 5-[[(2,3-diflurophenyl)methyl]thio]-7-[[2-hydroxy-1-(hydroxymethyl)-1-methylethyl]amino]-thiazolo[4,5-d]pyrimidin-2(3h)-one and therapeutic uses thereof |
| 04/01/2004 | CA2498760A1 Novel compound |
| 04/01/2004 | CA2492319A1 Macrocyclic pyrimidines, the production thereof and the use of the same as medicaments |
| 03/31/2004 | EP1401437A1 Immune response modifiers for the treatment of periodontal disease |
| 03/31/2004 | EP0874852B1 Oxazolidinone antibacterial agent with tricyclic substituents |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486311A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1486310A Pyrazole compounds useful as protein kinase inhibitors |
| 03/31/2004 | CN1143851C Penicillene compounds and derivatives therefrom |
| 03/30/2004 | US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 03/30/2004 | US6713477 1,4-benzthiazines or benzoxazines; matrix metalloproteinase inhibitors |
| 03/30/2004 | US6713475 Tricyclic benzodiazepines (cyclic oligopeptides), useful for treatment of hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal failure, stroke or thrombosis |
| 03/30/2004 | US6713471 Such as tert-butyl-1-methyl-6,7,9,12-tetrahydro-5h-pyrido-(4,3-b)(1,4) thiazepino(2,3,4-hi)indole-11(10h)-carboxylate; serotonin agonists and antagonists; central nervous system disorders |
| 03/30/2004 | US6713468 Methods of using thiazolobenzoheterocycles |
| 03/25/2004 | WO2004024074A2 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 03/25/2004 | WO2004000849A3 Tetracyclic arylsulfonyl indoles having serotonin receptor affinity |
| 03/25/2004 | WO2003086306B1 5ht2c receptor modulators |
| 03/25/2004 | WO2003077862A3 Potent, simplified derivatives of immunosuppressive agents |
| 03/25/2004 | WO2003014121A9 Compounds, derivatives, compositions, preparation and uses |
| 03/25/2004 | US20040058958 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 03/25/2004 | US20040058952 Urease inhibitors |
| 03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
| 03/25/2004 | US20040058931 Potassium channel inhibitors and method |
| 03/25/2004 | US20040058906 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | CA2498237A1 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 03/24/2004 | EP1399445A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 03/24/2004 | EP1399444A2 Novel heterocyclic compounds, method for preparing same and use thereof as medicines, in particular as anti-bacterial agents |
| 03/24/2004 | EP1399443A1 Nitrogen-containing bicyclic heterocycles for use as antibacterials |
| 03/24/2004 | CN1484638A I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands |
| 03/24/2004 | CN1142923C 12,13-modified epothilone derivatives |
| 03/23/2004 | US6710906 Controlled diffusion coefficient electrochromic materials for use in electrochromic mediums and associated electrochromic devices |
| 03/23/2004 | US6710055 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbo quinoline-8-sulfonylamino)-indole |
| 03/23/2004 | US6710041 Pyrrolo[2,1-B][3,1] benzothiazepines and their use for the preparation of medicaments with antipsychotic activity |
| 03/18/2004 | WO2004021984A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/18/2004 | WO2003035615A3 Tyrosine kinase inhibitors |
| 03/18/2004 | WO2003011222A3 Thrombin inhibitors |
| 03/18/2004 | US20040054171 Polymorphic forms of a 4H-thieno[3,2-E]-1,2,4-thiadiazine 1,1-dioxide derivative |
| 03/17/2004 | EP1305318B1 Process for the preparation of 9-amino substituted 9,10-dihydropyrrolo [2,1-b] [1,3]benzothiazepines |
| 03/16/2004 | US6706757 Chroman derivatives as 5-hydroxytryptamine-6 ligands |
| 03/16/2004 | US6706744 Hypoglycemic agents; antidiabetic agents |
| 03/16/2004 | US6706707 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 03/16/2004 | CA2096460C Dual action inhibitors |
| 03/16/2004 | CA2079143C Novel 2-substituted indane-2-carboxyalkyl derivatives useful as inhibitors of enkephalinase and ace |
| 03/11/2004 | WO2004020442A1 Selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 03/11/2004 | WO2004019907A1 Methods and reagents for treating infections of clostridium difficile and diseases associated therewith |
| 03/11/2004 | US20040049038 N-substituted with a methylene-bridged nonaromatic ring system, e.g., N-(2-(benzyloxy)-5,6,7,8,9,10-hexahydro-6,9-methanobenzo(a)(8)annulen-11-yl)-N'-(2,2,2-trifluoroethyl)-sulfamide; preventing or treating Alzheimer's Disease |
| 03/11/2004 | US20040049029 Process for preparing substance GM-95 |
| 03/11/2004 | US20040048884 3-aminoalkyluracil derivatives, e.g., 1-(2,6-Difluorobenzyl)-5-(3-methoxyphenyl)-6-methyl-3-(N-methyl-N-(2 -pyridylethyl)-aminoethyl)uracil; contraceptives; treating lupus, sex hormone related cancer, benign prostatic hypertrophy, etc. |
| 03/11/2004 | US20040048879 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient |